Helicobacter pylori (Hp) is a human pathogen that lives in the gastric mucosa of approximately 50% world's population causing gastritis, peptic ulcers, and cancer. An increase resistance to current drugs has sparked search for new Hp drug targets therapeutics. One target disruption nucleic acid production, which can be achieved by impeding synthesis 6-oxopurine nucleoside monophosphates, precur...